摘要
Cell death is important in restricting cancer growth, therefore one of the hallmarks of cancer is evasion of cell death. However, in certain circumstances cell death is used by cancer cells for tumor promotion. There are many forms of cell death. Programmed cell death is typically engaged when things go awry in cells as a mechanism of tumor suppression. There are different forms of programmed cell death including apoptosis, necroptosis, and ferroptosis. Apoptosis can occur via two distinct pathways, the intrinsic pathway, which engages the mitochondria, and the extrinsic pathway, which engages death receptors. The intrinsic mitochondrial pathway involves the BCL-2 family of proteins, the induction of mitochondrial outer membrane permeabilization, release of cytochrome c and ultimately cell death. The extrinsic pathway involves binding of ligands on cell death receptors, which in turn engage intracellular signaling pathways that ultimately result in release of cytochrome c and cell death. Necroptosis is a pro-inflammatory form of cell death that is involved during the process of tumorigenesis. In the tumor microenvironment, for example, necroptosis may be engaged to promote metastasis and inflammation. However, in other instances necroptosis is adopted by cancer cells for negative regulation of tumor growth. Necroptosis is initiated via the cell death receptors and engages downstream proteins RIPK1 and RIPK3 to form the so-called IIB necrosome complex. This results in phosphorylation of mixed lineage kinase domain-like protein (MLKL), which translocates to the plasma membrane and promotes necrosis through the disruption of the cell membrane integrity. Ferroptosis is pro-inflammatory and shows different morphological features than the other forms of cell death. For example, ferroptosis does not involve rupture and blebbing of the plasma membrane and is characterized by small mitochondria and condensed mitochondrial membrane density. At the molecular level, it involves activation of mitogen activated protein kinases (MAPKs) and accumulation of iron and reactive oxygen species (ROS). Autophagy is a process involving cellular degradation through the lysosome and has been shown to have opposing roles in cancer. On one hand, it can promote tumorigenesis in established tumor by providing intermediates for cellular metabolism, and on the other hand it can constrain tumor initiation by getting rid of toxic protein aggregates, damaged DNA, and reactive oxygen species. At the molecular level the process is regulated by various proteins such as 5′ AMP-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR), unc-51-like autophagy activating kinase 1 (ULK1), and others.